{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:09:27Z","timestamp":1782698967636,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1177\/1933719116675055","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:20:31Z","timestamp":1477959631000},"page":"1005-1013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1"],"prefix":"10.1007","volume":"24","author":[{"given":"Tung-Yueh","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"McCrary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Layman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"issue":"2","key":"24071005_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/humrep\/dep396","volume":"25","author":"SK Sunkara","year":"2010","unstructured":"Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A. The effect of intramural fibroids without uterine cavity involve-ment on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod. 2010;25(2):418\u2013429.","journal-title":"Hum Reprod"},{"issue":"2","key":"24071005_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.sult.2008.12.002","volume":"30","author":"SH Shen","year":"2009","unstructured":"Shen SH, Fennessy F, McDannold N, Jolesz F, Tempany C. Image-guided thermal therapy of uterine fibroids. Semin Ultra-sound CT MR. 2009;30(2):91\u2013104.","journal-title":"Semin Ultra-sound CT MR"},{"issue":"3","key":"24071005_CR3","doi-asserted-by":"publisher","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"24071005_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/IJWH.S51083","volume":"6","author":"AT Khan","year":"2014","unstructured":"Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current per-spectives. Int J Womens Health. 2014;6:95\u2013114.","journal-title":"Int J Womens Health"},{"issue":"1","key":"24071005_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","volume":"126","author":"J Tang","year":"2009","unstructured":"Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol. 2009;126(1):5\u201317.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"24071005_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/CAD.0b013e328330d95b","volume":"20","author":"Y Sun","year":"2009","unstructured":"Sun Y, Xun K, Wang Y, Chen X. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs. 2009;20(9):757\u2013769.","journal-title":"Anticancer Drugs"},{"issue":"4","key":"24071005_CR7","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.fertnstert.2015.01.010","volume":"103","author":"HL Wu","year":"2015","unstructured":"Wu HL, Chuang TY, Al-Hendy A, Diamond MP, Azziz R, Chen YH. Berberine inhibits the proliferation of human uterine leio-myoma cells. Fertil Steril. 2015;103(4):1098\u20131106.","journal-title":"Fertil Steril"},{"issue":"2","key":"24071005_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2013.01.006","volume":"168","author":"X Ke","year":"2013","unstructured":"Ke X, Dou F, Cheng Z, et al. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):199\u2013203.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"24071005_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1177\/1933719114542010","volume":"21","author":"SB Park","year":"2014","unstructured":"Park SB, Jee BC, Kim SH, Cho YJ, Han M. Cyclooxygenase-2 inhibitor, celecoxib, inhibits leiomyoma cell proliferation through the nuclear factor kappaB pathway. Reprod Sci. 2014;21(9):1187\u20131195.","journal-title":"Reprod Sci"},{"issue":"6","key":"24071005_CR10","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1210\/jc.2004-2303","volume":"90","author":"SJ Tsai","year":"2005","unstructured":"Tsai SJ, Lin SJ, Cheng YM, Chen HM, Wing LY. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas. J Clin Endocrinol Metab. 2005;90(6):3715\u20133723.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"24071005_CR11","doi-asserted-by":"publisher","first-page":"e69240","DOI":"10.1371\/journal.pone.0069240","volume":"8","author":"L Fu","year":"2013","unstructured":"Fu L, Chen W, Guo W, et al. Berberine targets AP-2\/hTERT, NF-kappaB\/COX-2, HIF-lalpha\/VEGF and cytochrome-c\/Caspase signaling to suppress human cancer cell growth. PLoS One. 2013;8(7):e69240.","journal-title":"PLoS One"},{"issue":"6","key":"24071005_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.LAB.0000017499.51216.3E","volume":"82","author":"SA Carney","year":"2002","unstructured":"Carney SA, Tahara H, Swartz CD, et al. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest. 2002;82(6):719\u2013728.","journal-title":"Lab Invest"},{"issue":"2","key":"24071005_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2011.04.002","volume":"307","author":"YY Hou","year":"2011","unstructured":"Hou YY, Cao WW, Li L, et al. MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett. 2011;307(2):182\u2013190.","journal-title":"Cancer Lett"},{"issue":"7","key":"24071005_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","volume":"107","author":"W Strzalka","year":"2011","unstructured":"Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regula-tion. Ann Bot. 2011;107(7):1127\u20131140.","journal-title":"Ann Bot"},{"issue":"Pt12","key":"24071005_CR15","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1242\/jcs.115.12.2461","volume":"115","author":"M Doree","year":"2002","unstructured":"Doree M, Hunt T. From Cdc2 to Cdkl: when did the cell cycle kinase join its cyclin partner? J Cell Sci. 2002;115(Pt 12): 2461\u20132464.","journal-title":"J Cell Sci"},{"issue":"5","key":"24071005_CR16","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1091\/mbc.e06-12-1092","volume":"18","author":"TK Fung","year":"2007","unstructured":"Fung TK, Ma HT, Poon RY. Specialized roles of the two mitotic cyclins in somatic cells: cyclin A as an activator of M phase-promoting factor. Mol Biol Cell. 2007;18(5):1861\u20131873.","journal-title":"Mol Biol Cell"},{"issue":"18","key":"24071005_CR17","doi-asserted-by":"publisher","first-page":"8493","DOI":"10.1073\/pnas.92.18.8493","volume":"92","author":"ML Agarwal","year":"1995","unstructured":"Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2\/M and the Gl cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995;92(18):8493\u20138497.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"24071005_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2007.11.031","volume":"13","author":"TC Hallstrom","year":"2008","unstructured":"Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between prolif-eration and cell death. Cancer Cell. 2008;13(1):11\u201322.","journal-title":"Cancer Cell"},{"key":"24071005_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1479-5876-12-22","volume":"12","author":"HW Qi","year":"2014","unstructured":"Qi HW, Xin LY, Xu X, Ji XX, Fan LH. Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis. J Transi Med. 2014;12:22.","journal-title":"J Transi Med"},{"issue":"6","key":"24071005_CR20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433\u20132442.","journal-title":"Endocrinology"},{"issue":"5","key":"24071005_CR21","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.dmpk.2015.08.006","volume":"30","author":"YP Chang","year":"2015","unstructured":"Chang YP, Huang CC, Shen CC, Tsai KC, Ueng YF. Differential inhibition of CYP1-catalyzed regioselective hydro-xylation of estradiol by berberine and its oxidative metabolites. Drug Metab Pharmacokinet. 2015;30(5):374\u2013383.","journal-title":"Drug Metab Pharmacokinet"},{"key":"24071005_CR22","first-page":"CD005292","volume-title":"Cochrane Database Syst Rev.","author":"JP Liu","year":"2013","unstructured":"Liu JP, Yang H, Xia Y, Cardini F. Herbal preparations for uterine fibroids. Cochrane Database Syst Rev. 2013;(4): CD005292."},{"key":"24071005_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6882-14-2","volume":"14","author":"NN Chen","year":"2014","unstructured":"Chen NN, Han M, Yang H, et al. Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids: a systematic review of randomised clinical trials. BMC Complement Altern Med. 2014;14:2.","journal-title":"BMC Complement Altern Med"},{"key":"24071005_CR24","first-page":"477","volume":"5","author":"E Roshdy","year":"2013","unstructured":"Roshdy E, Rajaratnam V, Maitra S, Sabry M, Allah AS, Al-Hendy A. Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study. Int J Womens Health. 2013;5:477\u2013486.","journal-title":"Int J Womens Health"},{"issue":"1\u20132","key":"24071005_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0303-7207(02)00230-7","volume":"196","author":"LC Hodges","year":"2002","unstructured":"Hodges LC, Houston KD, Hunter DS, et al. Transdominant sup-pression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Mol Cell Endocrinol. 2002; 196(1\u20132):11\u201320.","journal-title":"Mol Cell Endocrinol"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116675055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719116675055","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719116675055\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719116675055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116675055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:56:32Z","timestamp":1656813392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719116675055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["24071005"],"URL":"https:\/\/doi.org\/10.1177\/1933719116675055","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"23 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}